PMID- 37332011 OWN - NLM STAT- MEDLINE DCOM- 20231023 LR - 20231023 IS - 1440-1746 (Electronic) IS - 0815-9319 (Linking) VI - 38 IP - 10 DP - 2023 Oct TI - Relationship between gluten availability and celiac disease prevalence: A geo-epidemiologic systematic review. PG - 1695-1709 LID - 10.1111/jgh.16260 [doi] AB - Celiac disease is a global disease requiring genetic susceptibility and gluten exposure to trigger immune-mediated enteropathy. The effect of the degree of gluten-containing grain availability on celiac disease prevalence is unknown. Our objective was to compare country-based gluten availability to celiac prevalence using a systematic literature review. We searched MEDLINE, Embase, Cochrane, and Scopus until May 2021. We included population-based serum screening with confirmatory testing (second serological study or small intestine biopsy) and excluded specific, high-risk, or referral populations. We determined country-specific gluten availability using the United Nations food balance for wheat, barley, and rye. Human leukocyte antigen (HLA) frequencies were obtained from allelefrequencies.net. The primary outcome was association between gluten-containing grain availability and celiac disease prevalence. Generalized linear mixed models method with Poisson's link was used for analysis. We identified 5641 articles and included 120 studies on 427 146 subjects from 41 countries. Celiac disease prevalence was 0-3.1%, median 0.75% (interquartile range 0.35, 1.22). Median wheat supply was 246 g/capita/day (interquartile range 214.8, 360.7). The risk ratio (RR) for wheat availability on celiac disease was 1.002 (95% confidence interval [CI]: 1.0001, 1.004, P = 0.036). A protective association was seen with barley, RR 0.973 (95% CI: 0.956, 0.99, P = 0.003), and rye, RR 0.989 (95% CI: 0.982, 0.997, P = 0.006). The RR for gross domestic product on celiac disease prevalence was 1.009 (95% CI: 1.005, 1.014, P < 0.001). The RR for HLA-DQ2 was 0.982 (95% CI: 0.979, 0.986, P < 0.001), and that for HLA-DQ8 was 0.957 (95% CI: 0.950, 0.964, P < 0.001). In this geo-epidemiologic study, gluten-containing grain availability showed mixed associations with celiac disease prevalence. CI - (c) 2023 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. FAU - Jansson-Knodell, Claire L AU - Jansson-Knodell CL AUID- ORCID: 0000-0001-6148-4203 AD - Division of Gastroenterology, Hepatology, and Nutrition, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio, USA. FAU - Celdir, Melis G AU - Celdir MG AD - Department of Gastroenterology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA. FAU - Hujoel, Isabel A AU - Hujoel IA AD - Department of Gastroenterology, University of Washington, Seattle, Washington, USA. FAU - Lyu, Ruishen AU - Lyu R AD - Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA. FAU - Gardinier, David AU - Gardinier D AD - Division of Gastroenterology, Hepatology, and Nutrition, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio, USA. FAU - Weekley, Kendra AU - Weekley K AD - Division of Gastroenterology, Hepatology, and Nutrition, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio, USA. FAU - Prokop, Larry J AU - Prokop LJ AD - Mayo Clinic Libraries, Mayo Clinic, Rochester, Minnesota, USA. FAU - Rubio-Tapia, Alberto AU - Rubio-Tapia A AD - Division of Gastroenterology, Hepatology, and Nutrition, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio, USA. LA - eng GR - AGA2022-13-07/AGA Research Foundation/ PT - Journal Article PT - Review PT - Systematic Review DEP - 20230618 PL - Australia TA - J Gastroenterol Hepatol JT - Journal of gastroenterology and hepatology JID - 8607909 RN - 8002-80-0 (Glutens) SB - IM MH - Humans MH - *Celiac Disease/epidemiology/etiology/diagnosis MH - Glutens/adverse effects MH - Genetic Predisposition to Disease MH - Biopsy OTO - NOTNLM OT - biopsy OT - epidemiology OT - global OT - grain OT - seropositive EDAT- 2023/06/19 00:42 MHDA- 2023/10/23 00:42 CRDT- 2023/06/18 23:35 PHST- 2023/05/04 00:00 [revised] PHST- 2023/03/10 00:00 [received] PHST- 2023/05/31 00:00 [accepted] PHST- 2023/10/23 00:42 [medline] PHST- 2023/06/19 00:42 [pubmed] PHST- 2023/06/18 23:35 [entrez] AID - 10.1111/jgh.16260 [doi] PST - ppublish SO - J Gastroenterol Hepatol. 2023 Oct;38(10):1695-1709. doi: 10.1111/jgh.16260. Epub 2023 Jun 18.